Infectious mononucleosis, other infections and prostate-specific antigen concentration as a marker of prostate involvement during infection

Siobhan Sutcliffe, Remington L. Nevin, Ratna Pakpahan, Debra J. Elliott, Marvin E. Langston, Angelo Michael Demarzo, Charlotte A Gaydos, William B Isaacs, William G Nelson, Lori J Sokoll, Patrick Walsh, Jonathan Mark Zenilman, Steven B. Cersovsky, Elizabeth A Platz

Research output: Contribution to journalArticle

Abstract

Although Epstein-Barr virus has been detected in prostate tissue, no associations have been observed with prostate cancer in the few studies conducted to date. One possible reason for these null findings may be use of cumulative exposure measures that do not inform the timing of infection, i.e., childhood versus adolescence/early adulthood when infection is more likely to manifest as infectious mononucleosis (IM). We sought to determine the influence of young adult-onset IM on the prostate by measuring prostate-specific antigen (PSA) as a marker of prostate inflammation/damage among U.S. military members. We defined IM cases as men diagnosed with IM from 1998 to 2003 (n = 55) and controls as men without an IM diagnosis (n = 255). We selected two archived serum specimens for each participant, the first collected after diagnosis for cases and one randomly selected from 1998 to 2003 for controls (index), as well as the preceding specimen (preindex). PSA was measured in each specimen. To explore the specificity of our findings for prostate as opposed to systemic inflammation, we performed a post hoc comparison of other infectious disease cases without genitourinary involvement (n = 90) and controls (n = 220). We found that IM cases were more likely to have a large PSA rise than controls (≥20 ng/mL: 19.7% versus 8.8%, p = 0.027; ≥40% rise: 25.7% versus 9.4%, p = 0.0021), as were other infectious disease cases (25.7% versus 14.0%, p = 0.020; 27.7% versus 18.0%, p = 0.092). These findings suggest that, in addition to rising because of prostate infection, PSA may also rise because of systemic inflammation, which could have implications for PSA interpretation in older men.

Original languageEnglish (US)
Pages (from-to)2221-2230
Number of pages10
JournalInternational Journal of Cancer
Volume138
Issue number9
DOIs
StatePublished - May 1 2016

Fingerprint

Infectious Mononucleosis
Prostate-Specific Antigen
Prostate
Infection
Inflammation
Communicable Diseases
Human Herpesvirus 4
Young Adult
Prostatic Neoplasms
Serum

Keywords

  • epidemiology
  • infection
  • infectious mononucleosis
  • prostate cancer
  • prostate-specific antigen

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Infectious mononucleosis, other infections and prostate-specific antigen concentration as a marker of prostate involvement during infection. / Sutcliffe, Siobhan; Nevin, Remington L.; Pakpahan, Ratna; Elliott, Debra J.; Langston, Marvin E.; Demarzo, Angelo Michael; Gaydos, Charlotte A; Isaacs, William B; Nelson, William G; Sokoll, Lori J; Walsh, Patrick; Zenilman, Jonathan Mark; Cersovsky, Steven B.; Platz, Elizabeth A.

In: International Journal of Cancer, Vol. 138, No. 9, 01.05.2016, p. 2221-2230.

Research output: Contribution to journalArticle

@article{ed15763c051c49a2926a678023ffea78,
title = "Infectious mononucleosis, other infections and prostate-specific antigen concentration as a marker of prostate involvement during infection",
abstract = "Although Epstein-Barr virus has been detected in prostate tissue, no associations have been observed with prostate cancer in the few studies conducted to date. One possible reason for these null findings may be use of cumulative exposure measures that do not inform the timing of infection, i.e., childhood versus adolescence/early adulthood when infection is more likely to manifest as infectious mononucleosis (IM). We sought to determine the influence of young adult-onset IM on the prostate by measuring prostate-specific antigen (PSA) as a marker of prostate inflammation/damage among U.S. military members. We defined IM cases as men diagnosed with IM from 1998 to 2003 (n = 55) and controls as men without an IM diagnosis (n = 255). We selected two archived serum specimens for each participant, the first collected after diagnosis for cases and one randomly selected from 1998 to 2003 for controls (index), as well as the preceding specimen (preindex). PSA was measured in each specimen. To explore the specificity of our findings for prostate as opposed to systemic inflammation, we performed a post hoc comparison of other infectious disease cases without genitourinary involvement (n = 90) and controls (n = 220). We found that IM cases were more likely to have a large PSA rise than controls (≥20 ng/mL: 19.7{\%} versus 8.8{\%}, p = 0.027; ≥40{\%} rise: 25.7{\%} versus 9.4{\%}, p = 0.0021), as were other infectious disease cases (25.7{\%} versus 14.0{\%}, p = 0.020; 27.7{\%} versus 18.0{\%}, p = 0.092). These findings suggest that, in addition to rising because of prostate infection, PSA may also rise because of systemic inflammation, which could have implications for PSA interpretation in older men.",
keywords = "epidemiology, infection, infectious mononucleosis, prostate cancer, prostate-specific antigen",
author = "Siobhan Sutcliffe and Nevin, {Remington L.} and Ratna Pakpahan and Elliott, {Debra J.} and Langston, {Marvin E.} and Demarzo, {Angelo Michael} and Gaydos, {Charlotte A} and Isaacs, {William B} and Nelson, {William G} and Sokoll, {Lori J} and Patrick Walsh and Zenilman, {Jonathan Mark} and Cersovsky, {Steven B.} and Platz, {Elizabeth A}",
year = "2016",
month = "5",
day = "1",
doi = "10.1002/ijc.29966",
language = "English (US)",
volume = "138",
pages = "2221--2230",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "9",

}

TY - JOUR

T1 - Infectious mononucleosis, other infections and prostate-specific antigen concentration as a marker of prostate involvement during infection

AU - Sutcliffe, Siobhan

AU - Nevin, Remington L.

AU - Pakpahan, Ratna

AU - Elliott, Debra J.

AU - Langston, Marvin E.

AU - Demarzo, Angelo Michael

AU - Gaydos, Charlotte A

AU - Isaacs, William B

AU - Nelson, William G

AU - Sokoll, Lori J

AU - Walsh, Patrick

AU - Zenilman, Jonathan Mark

AU - Cersovsky, Steven B.

AU - Platz, Elizabeth A

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Although Epstein-Barr virus has been detected in prostate tissue, no associations have been observed with prostate cancer in the few studies conducted to date. One possible reason for these null findings may be use of cumulative exposure measures that do not inform the timing of infection, i.e., childhood versus adolescence/early adulthood when infection is more likely to manifest as infectious mononucleosis (IM). We sought to determine the influence of young adult-onset IM on the prostate by measuring prostate-specific antigen (PSA) as a marker of prostate inflammation/damage among U.S. military members. We defined IM cases as men diagnosed with IM from 1998 to 2003 (n = 55) and controls as men without an IM diagnosis (n = 255). We selected two archived serum specimens for each participant, the first collected after diagnosis for cases and one randomly selected from 1998 to 2003 for controls (index), as well as the preceding specimen (preindex). PSA was measured in each specimen. To explore the specificity of our findings for prostate as opposed to systemic inflammation, we performed a post hoc comparison of other infectious disease cases without genitourinary involvement (n = 90) and controls (n = 220). We found that IM cases were more likely to have a large PSA rise than controls (≥20 ng/mL: 19.7% versus 8.8%, p = 0.027; ≥40% rise: 25.7% versus 9.4%, p = 0.0021), as were other infectious disease cases (25.7% versus 14.0%, p = 0.020; 27.7% versus 18.0%, p = 0.092). These findings suggest that, in addition to rising because of prostate infection, PSA may also rise because of systemic inflammation, which could have implications for PSA interpretation in older men.

AB - Although Epstein-Barr virus has been detected in prostate tissue, no associations have been observed with prostate cancer in the few studies conducted to date. One possible reason for these null findings may be use of cumulative exposure measures that do not inform the timing of infection, i.e., childhood versus adolescence/early adulthood when infection is more likely to manifest as infectious mononucleosis (IM). We sought to determine the influence of young adult-onset IM on the prostate by measuring prostate-specific antigen (PSA) as a marker of prostate inflammation/damage among U.S. military members. We defined IM cases as men diagnosed with IM from 1998 to 2003 (n = 55) and controls as men without an IM diagnosis (n = 255). We selected two archived serum specimens for each participant, the first collected after diagnosis for cases and one randomly selected from 1998 to 2003 for controls (index), as well as the preceding specimen (preindex). PSA was measured in each specimen. To explore the specificity of our findings for prostate as opposed to systemic inflammation, we performed a post hoc comparison of other infectious disease cases without genitourinary involvement (n = 90) and controls (n = 220). We found that IM cases were more likely to have a large PSA rise than controls (≥20 ng/mL: 19.7% versus 8.8%, p = 0.027; ≥40% rise: 25.7% versus 9.4%, p = 0.0021), as were other infectious disease cases (25.7% versus 14.0%, p = 0.020; 27.7% versus 18.0%, p = 0.092). These findings suggest that, in addition to rising because of prostate infection, PSA may also rise because of systemic inflammation, which could have implications for PSA interpretation in older men.

KW - epidemiology

KW - infection

KW - infectious mononucleosis

KW - prostate cancer

KW - prostate-specific antigen

UR - http://www.scopus.com/inward/record.url?scp=84958932656&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958932656&partnerID=8YFLogxK

U2 - 10.1002/ijc.29966

DO - 10.1002/ijc.29966

M3 - Article

VL - 138

SP - 2221

EP - 2230

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 9

ER -